Eric Boersma

Erasmus MC

Papers

1

Total Citations

157

H-Index

1

About

Eric Boersma is a leading cardiovascular epidemiologist whose work bridges lipidomics and clinical outcomes in coronary artery disease (CAD). His research centers on identifying molecular lipid species that predict long-term prognosis, refining risk stratification beyond traditional biomarkers. In a landmark 2018 study, Boersma and his team demonstrated that specific plasma lipid species and ceramide ratios are strongly associated with major adverse cardiac events over nearly five years of follow-up in CAD patients. This work, cited over 150 times, has advanced the understanding of how lipid metabolism directly influences disease progression and patient outcomes. Boersma’s contributions are pivotal in translating molecular lipid profiling into actionable clinical tools, offering a more precise approach to managing cardiovascular risk. His findings have influenced subsequent guidelines and sparked further investigation into lipid-based therapeutics. Through rigorous cohort studies and innovative biomarker discovery, Boersma continues to shape precision cardiology, helping clinicians identify high-risk patients who may benefit from intensified preventive strategies.

Research Focus

Key Achievements

1
H-Index
1
Papers
157
Total Citations
157
Avg Citations/Paper
🏆 Most Cited Paper
Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients
157 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Erasmus MC

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago